Chondroitinase ABC promotes functional recovery after spinal cord injury
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
The inability of axons to regenerate after a spinal cord injury in the adult mammalian central nervous system (CNS) can lead to permanent paralysis. At sites of CNS injury, a glial scar develops, containing extracellular matrix molecules including chondroitin sulphate proteoglycans (CSPGs). CSPGs are inhibitory to axon growth in vitro, and regenerating axons stop at CSPG-rich regions in vivo. Removing CSPG glycosaminoglycan (GAG) chains attenuates CSPG inhibitory activity. To test the functional effects of degrading chondroitin sulphate (CS)-GAG after spinal cord injury, we delivered chondroitinase ABC (ChABC) to the lesioned dorsal columns of adult rats. We show that intrathecal treatment with ChABC degraded CS-GAG at the injury site, upregulated a regeneration-associated protein in injured neurons, and promoted regeneration of both ascending sensory projections and descending corticospinal tract axons. ChABC treatment also restored post-synaptic activity below the lesion after electrical stimulation of corticospinal neurons, and promoted functional recovery of locomotor and proprioceptive behaviours. Our results demonstrate that CSPGs are important inhibitory molecules in vivo and suggest that their manipulation will be useful for treatment of human spinal injuries.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Degradation of PNNs has been shown to reactivate early life-like plasticity also in the spinal cord and fear circuitry189,190.”
From Neuronal plasticity and neurotrophic factors in drug responses (2017) · cites this paper as [189]
In the citing paper
“In rats, iPlasticity induced either by ChABC or fluoxetine improves recovery from spinal cord lesion189,201.”
From Neuronal plasticity and neurotrophic factors in drug responses (2017) · cites this paper as [189]
In the citing paper
“As chABC removes GAG side chains from CSPGs (Bradbury et al., 2002), these results suggest that the neuroprotective effects of PNNs may be attributed to the CS-side chains of CSPGs.”
From The Perineuronal ‘Safety’ Net? Perineuronal Net Abnormalities in Neurological Disorders (2018) · cites this paper as Bradbury et al., 2002
In the citing paper
“CSPG degradation via application of chABC promoted regeneration of dorsal column axons after injury.”
From The Perineuronal ‘Safety’ Net? Perineuronal Net Abnormalities in Neurological Disorders (2018) · cites this paper as Bradbury et al., 2002
In the citing paper
“but also contributed to expanded receptive fields of uninjured primary afferents (Bradbury et al., 2002; Massey et al., 2006).”
From The Perineuronal ‘Safety’ Net? Perineuronal Net Abnormalities in Neurological Disorders (2018) · cites this paper as Bradbury et al., 2002
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The glial scar and central nervous system repair
Fawcett, J. W., & Asher, R. A. (1999) · Brain Research Bulletin · doi:10.1016/s0361-9230(99)00072-6 · Cited by 1,803 · cited 1×
“At sites of CNS injury, a glial scar develops, containing extracellular matrix molecules including chondroitin sulphate proteoglycans (CSPGs)”
BackgroundSelf-citationMcKeon, R., Schreiber, R., Rudge, J., & Silver, J. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-11-03398.1991 · Cited by 1,188
Recovery from spinal cord injury mediated by antibodies to neurite growth inhibitors
Bregman, B. S., Kunkel-Bagden, E., Schnell, L., Dai, H. N., Gao, D., & Schwab, M. E. (1995) · Nature · doi:10.1038/378498a0 · Cited by 716
Davies, S. J. A., Goucher, D. R., Doller, C., & Silver, J. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-14-05810.1999 · Cited by 606 · cited 1×
“, and regenerating axons stop at CSPG-rich regions in vivo”
BackgroundMoon, L. D. F., Asher, R. A., Rhodes, K. E., & Fawcett, J. W. (2001) · Nature Neuroscience · doi:10.1038/87415 · Cited by 562
Self-citationFunctional regeneration of sensory axons into the adult spinal cord
Ramer, M. S., Priestley, J. V., & McMahon, S. B. (2000) · Nature · doi:10.1038/35002084 · Cited by 517
Self-citationMckeon, R. J., Höke, A., & Silver, J. (1995) · Experimental Neurology · doi:10.1006/exnr.1995.1081 · Cited by 486
Neurocan Is Upregulated in Injured Brain and in Cytokine-Treated Astrocytes
Asher, R. A., Morgenstern, D. A., Fidler, P. S., Adcock, K. H., Oohira, A., Braistead, J. E., Levine, J. M., Margolis, R. U., Rogers, J. H., & Fawcett, J. W. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-07-02427.2000 · Cited by 482
Self-citationMcKeon, R. J., Jurynec, M. J., & Buck, C. R. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-24-10778.1999 · Cited by 480
Increased expression of the NG2 chondroitin-sulfate proteoglycan after brain injury
Levine, J. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-08-04716.1994 · Cited by 393
Cited by
Regeneration beyond the glial scar
Silver, J., & Miller, J. H. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1326 · Cited by 3,078
“Intrathecal application of chondroitinase to animals with bilateral dorsal column lesions resulted in degradation of CSPG at the lesion site, and allowed both ascending sensory and descending motor axon regeneration through, and perhaps even slightly past, the lesio”
BackgroundAhuja, C. S., Wilson, J. R., Nori, S., Kotter, M. R. N., Druschel, C., Curt, A., & Fehlings, M. G. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.18 · Cited by 2,441
Genomic analysis of reactive astrogliosis
Zamanian, J. L., Xu, L., Foo, L. C., Nouri, N., Zhou, L., Giffard, R. G., & Barres, B. A. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.6221-11.2012 · Cited by 2,404
“For instance, reactive astrocytes can inhibit axon regeneration after CNS injury (McKeon et al., 1991; Bradbury et al., 2002; Fitch and Silver, 2008; Alilain et al., 2011) and can produce proinflammatory cytokines that exacerbate spinal cord injuries (Brambilla et al.”
BackgroundKigerl, K. A., Gensel, J. C., Ankeny, D. P., Alexander, J. K., Donnelly, D. J., & Popovich, P. G. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3257-09.2009 · Cited by 2,130
“Others have shown that chABC can be used in vivo and in vitro to degrade inhibitory proteoglycan substrates and promote axon sprouting and regeneration (Bradbury et al., 2002; Steinmetz et al., 2005).”
BackgroundLiang, H., Liang, P., Xu, Y., Wu, J., Liang, T., & Xu, X. (2009) · Journal of Neurotrauma · doi:10.1089/neu.2008.0850 · Cited by 1,750
“…of inhibitory molecules (Nogo-A), or degradation of extracellular matrix molecules (chondroitin sulfate), have been shown to stimulate the out-growth of damaged axons and protect them from further damage (Koda et al., 2007; Taylor et al., 2006; Atalay et al., 2007; Bradbury et al., 2002).”
Metadata
- Authors
- Bradbury, E. J., Moon, L. D. F., Popat, R. J., King, V. R., Bennett, G. S., Patel, P. N., Fawcett, J. W., & McMahon, S. B.
- Affiliations
- King's College London (GB)
- University of Cambridge (GB)
- University of London (GB)
- Corresponding author
- Bradbury, Elizabeth J.
- ORCID
- Venue
- Nature
- Published
- 2002-04
- Volume
- 416
- Issue
- 6881
- Pages
- 636-640
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2012928251
- Cited by
- 2,357
- References
- 31
- Citations by year
- 2026: 63 · 2025: 75 · 2024: 54 · 2023: 73 · 2022: 98 · 2021: 95 · 2020: 116 · 2019: 91 · 2018: 109 · 2017: 96 · 2016: 104 · 2015: 111 · 2014: 131 · 2013: 108 · 2012: 137
- FWCI
- 63.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Spinal Cord Injury Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
- Keywords
- chondroitinase ABC, spinal cord injury, chondroitin sulfate proteoglycans, glycosaminoglycan degradation, axon regeneration, glial scar, corticospinal tract, sensory axon regeneration, locomotor recovery, proprioception, central nervous system injury
- MeSH terms
- Animals, Axons, Electrophysiology, Ganglia, Spinal, Humans, Isoenzymes, Male, Motor Activity, Nerve Crush, Nerve Regeneration, Neurons, Protein Kinase C, Psychomotor Performance, Spinal Cord Injuries, Up-Regulation, Rats, Wistar, Chondroitin ABC Lyase, GAP-43 Protein, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.